Record financial year for Analytik Jena AG

Corporate news announcement processed and transmitted by Hugin AS.
The issuer is solely responsible for the content of this
announcement.
----------------------------------------------------------------------
--------------

- Focus on instrument business of the Technology segment implemented
- Sales in the instrument business increased by 23.1%
- Operating result up by 29.9 % to EUR 4,709 thousand

The 2007/2008 financial year was a very strong one for Analytik Jena.
Significant sales growth in the continued instrument business, a
rising operating result and innovative, forward-looking projects
confirm the positive trend of the Jena-based company.

During the financial year, the successful growth of Analytik Jena AG
continued in all units of the instrument business. Sales of EUR
53,079 thousand (previous year: EUR 43,125 thousand) and an increase
of 23.1% on the basis of organic growth provide impressive evidence
of this. The increases were generated in equal measure from the three
business units of analytical solutions, bio solutions and optical
solutions, all of which achieved new records for earnings.

For the first time, the analytical solutions business unit exceeded
the EUR 40.0 million mark. Total sales amounted to EUR 40,225
thousand (previous year: EUR 32,624 thousand). This corresponds to a
23.3% increase. The optical solutions business unit, our consumer
division, also reported record figures. Sales increased by 16.8% from
EUR 7,306 thousand to EUR 8,537 thousand. The highest sales were
achieved with products of the bio solutions business unit. The
extensive and growing product portfolio in conjunction with the
development of sales channels are having a positive effect. In the
past financial year, sales increased by 35.1% to EUR 4,317 thousand
(previous year: EUR 3,195 thousand). Including the discontinued
project solutions business unit, consolidated net sales decreased
slightly year-on-year by 1.6% to EUR 68,136 thousand (previous year:
EUR 69,265 thousand) taking consolidated sales for a total of only
seven months into consideration.

The export ratio of 73.0% (previous year: 76.9%) underlines the
successful marketing of the products worldwide. This trend continued
to be particularly successful in the growth market of Asia. Goods
with a value of EUR 15,770 thousand, 28.7% more than in the previous
year, were exported to this region. Our Japanese subsidiary
contributed to this, doubling its sales. US sales totalled EUR 4,480
thousand (previous year: EUR 3,865 thousand), an increase of 15.9%.
In Germany, sales rose to EUR 18,403 thousand, an increase of 15.2%
(previous year: EUR 15,972 thousand). Sales in Europe declined from
EUR 32,249 thousand to EUR 26,457 thousand as a result of
discontinuing the project solutions business unit.

Thanks to the higher contribution made by the instrument business to
consolidated net sales, a 42.7% gross margin was achieved (previous
year: 38.2%). There was an above-average increase in gross profit of
9.8% to EUR 29,080 thousand (previous year: EUR 26,491 thousand)
compared with sales. Selling expenses for the instrument business
amounted to EUR 13,413 thousand (previous year: EUR 11,176 thousand),
a 20.0% increase over the previous year. This development was the
result of increased sales-dependent selling expenses, such as
commissions and logistics costs, as well as significant increases in
marketing activities, the expansion of our organisation in China and
our cost-intensive attendance of three trade fairs: BIOTECHNICA in
Hanover in October 2007, Analytica in Munich in May 2008 and the
Jaima Show in Japan in September 2008. Administrative expenses fell
by 2.7% from EUR 4,732 thousand to EUR 4,603 thousand due to the
strategic decision to focus on the instrument business. Net research
and development expenses decreased slightly to EUR 5,075 thousand
(previous year: EUR 5,495 thousand) as a result of increased R&D
grants.

Total assets of Analytik Jena as at 30 September 2008 declined from
EUR 63,141 to EUR 57,418 thousand as a result of the sale of 51.0% of
shares in AJZ Engineering GmbH, Jena, (deconsolidation of project
business).
Earnings before interest, taxes, depreciation and amortisation
(EBITDA) increased to EUR 6,893 thousand (previous year: EUR 5,824
thousand). Operating profit (EBIT) increased by 29.9 % to EUR 4,709
thousand (previous year: EUR 3,625 thousand). On the basis of the
sole continued instrument business unit, the operating result was EUR
4,744 thousand (previous year: EUR 3,289 thousand), which corresponds
to an EBIT margin of 8.9%. The annual result in the instrument
business benefited strongly from the operating improvement, with a
74.1% increase to EUR 3,292 thousand (previous year: EUR 1,891
thousand). In the discontinued project solutions business unit, EBIT
amounted to EUR -35 thousand as at the date of closing. As of 30
September 2008, the Group generated net profit attributable to the
shareholders of the parent company in the amount of EUR 2,384
thousand (previous year: EUR 1,876 thousand), corresponding to a
27.1% increase, after deduction of the earnings share of minority
shareholders. Earnings per share increased by 27.5% to EUR 0.51 per
share (previous year: EUR 0.40).

As of 30 September 2008, the continued instruments business unit and
the discontinued project business had a total of 655 employees
(previous year: 592). The sole continued instrument business had 536
employees (previous year: 478).

Klaus Berka had this to say about the financial year and the outlook
for the future: "Concentration. Innovation. Growth -Analytik Jena AG
proved itself capable of all these in the 2007/2008 financial year.
We will continue to focus on our core business in a difficult overall
economic environment. We are positive that our innovative products
will enable us to continue to win over the market and grow in the new
financial year."

Please find the key figures of the annual year under: www.aj-group.de
and the link: Finanzzentrum

Please find the complete annual report published at 3 pm under:
www.aj-group.de and the link: financial reports
Contact:
Dr. Mario Voigt
Analytik Jena AG
Corporate Communications and Investor Relations
Konrad-Zuse-Str.1
07745 Jena

tel. ++493641779281
mail. m.voigt@analytik-jena.de

--- End of Message ---

Analytik Jena AG
Konrad-Zuse-Straße 1 Jena Germany

WKN: 521350 ;
ISIN: DE0005213508 ; Index: Prime All Share;
Listed: Geregelter Markt in Frankfurter Wertpapierbörse, Prime
Standard in Frankfurter Wertpapierbörse,
Freiverkehr in Bayerische Börse München, Freiverkehr in Börse Berlin,

Freiverkehr in Börse Düsseldorf, Freiverkehr in Börse Stuttgart,

Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr
in Niedersächsische Börse zu Hannover;
Copyright © Hugin AS 2008. All rights reserved.